Qiagen N.V.

 ETR:QIA ISIN:NL0000240000

Feb 9, 2012

OVERVIEW |  NEWS |  MULTIMEDIA  | RESEARCH


 

Qiagen N.V. Company Summary

 

COMPANY DATA

 
Company Homepage www.qiagen.com
 

Key Developments: Qiagen N.V.
 Qiagen N.V. (FRA:QIA) QIAGEN Introduces CE-marked Molecular Assay For The Cancer Biomarker K-ras
NOV 11, 2008 09:23 - Article Views: 821
Qiagen N.V. (FRA:QIA) Pyrosequencing-based molecular test detects and profiles genetic mutations to predict responses to EGFR inhibitor therapies in colorectal cancer patients
 Qiagen N.V. (FRA:QIA) QIAGEN Reports Strong Third Quarter 2008 Results
NOV 11, 2008 08:49 - Article Views: 1,486
Qiagen N.V. (FRA:QIA) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
 Qiagen N.V. (FRA:QIA) QIAGEN And Institute For Animal Health Enter Partnership In Bluetongue Testing
NOV 6, 2008 17:03 - Article Views: 386
Qiagen N.V. (FRA:QIA) Worldwide license agreement expands the Company's veterinary assay portfolio and aims to contain future outbreaks of the devastating viral disease
 Qiagen N.V. (FRA:QIA) QIAGEN Acquires Biosystems Business From Biotage
OCT 1, 2008 16:05 - Article Views: 419
Qiagen N.V. (FRA:QIA) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
 Qiagen N.V. (FRA:QIA) QIAGEN And Chinese Academy Of Sciences Form Collaboration For Development Of New Molecular Food Safety Tests
SEP 25, 2008 14:03 - Article Views: 294
Qiagen N.V. (FRA:QIA) Cooperation aims to better detect contaminations in dairy and other food products in China and other Asian countries
 Qiagen N.V.(NASDAQ:QGEN); QIAGEN Unveils Diagnostic Assay In The EU To Detect Genetic Variation
Causing Adverse Reactions In AIDS Patients

AUG 19, 2008 16:47 - Article Views: 477
HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future

450 COMPANY PROFILE VIEWS

 
This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 18) (Since Published: 450) 
 

Site Search

 
 ENGLISH   All Languages

MARKETS

 

 S&P 500
NASDAQ:QGEN
Delayed Data:
Chart by Google

ABN Newswire on iPhone/iPad

Download from Apple

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade